Submission of Half Year results - September 2025

Negative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+18.8%Reaction day

₹119.80

prior close

₹120.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+19.3% vs market

Pesticides & Agrochemicals peers, median of 27sector+0.0%+18.8% vs sector

On the reaction day the stock moved 19.3 pts more than Nifty Microcap 250 and 18.8 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+18.8-0.5+19.3+0.0+18.8

Next day

+10.4-1.0+11.4-0.4+10.7

+22.7-2.1+24.8-1.2+23.9

+15.7-4.4+20.1-2.6+18.3

+14.4-2.6+16.9-1.7+16.0

+16.8-3.2+20.0-2.8+19.6

+15.2-2.5+17.7-1.8+17.0

15d

+53.5-1.7+55.2-0.5+54.0

+62.8-0.3+63.1-1.6+64.3

+50.1-5.0+55.1-8.6+58.7

+32.7-11.6+44.3-15.0+47.7

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mahamaya Lifesciences (BSE SME, Scrip Code: 544611), an agro-crop protection company, reported its H1 FY26 (April–September 2025) results. Standalone revenue from operations rose to ₹16,306.37 lakhs from ₹14,623.12 lakhs in H1 FY25, an increase of about 11.5%. Profit after tax grew to ₹852.56 lakhs (₹725.25 lakhs earlier), with EPS at ₹4.80 versus ₹4.48. Consolidated PAT stood at ₹836.88 lakhs. Auditor N Naresh & Co. issued an unmodified limited review report with no qualifications. However, operating cash flow was sharply negative at ₹(689.75) lakhs standalone and ₹(681.75) lakhs consolidated, compared to ₹(175.36) lakhs in H1 FY25, driven mainly by a large build-up in inventory and trade receivables. Short-term borrowings also climbed to ₹6,370.73 lakhs from ₹4,186.70 lakhs.

Likely market impact

Topline and profit growth are steady and earnings are clean, but the widening negative operating cash flow and rising short-term debt signal working-capital stress that investors should monitor closely.